Monday, February 6, 2023
No Result
View All Result
  • Media
Support Us
Macdonald-Laurier Institute
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Energy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Energy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media
No Result
View All Result
Macdonald-Laurier Institute

Why Canadians should be concerned about Americans buying our drugs: New MLI Paper

November 2, 2020
in Domestic Policy Program, Foreign Affairs, Foreign Policy Program, Health, Health care - papers, Latest News, Papers, Releases, United States
Reading Time: 3 mins read
A A

OTTAWA, ON (November 2, 2020): The drama of the upcoming American election continues to fascinate Canadians. However, a key election issue that could have a serious impact on Canadians’ own health and wellbeing has gone largely unnoticed. An old idea for addressing America’s perceived problem of high-priced prescription drugs is back in a big way.

During the campaign, Trump promised that new regulations would allow US states to import medicines from Canada “at a fraction of the price” paid in the US. Though the idea is championed by President Donald Trump and state legislators, it has bipartisan support, notably by Democrats Bernie Sanders and presidential nominee Joe Biden.

In the latest MLI paper, “Americans Are After Our Drugs Again: Why and What Can We Do About It?” author Brian Ferguson argues that the resurgence of the notion of drug re-importation is something that should greatly concern Canadians.

As Ferguson explains, drug reimportation schemes usually envision individual states making large bulk purchases from Canadian suppliers. Such action would require approval from Washington to permit bulk importation nationally. This would significantly disrupt the Canadian supply of pharmaceuticals, given the sheer size of American markets. A widely cited study estimated that if 20 percent of US prescriptions were filled from Canadian re-imports, the Canadian supply would be exhausted in 155 days.

One can look towards the EU, where parallel import of drugs became a significant issue within the single market. A number of countries, such as Greece and Spain, employed price control regulations making them natural targets of supply for higher-price EU countries like Germany. This is the kind of situation that Canadian policy-makers fear will arise here under the various American proposals.

Ferguson finds that the evidence from the European example supports the view that the bulk of the financial benefit from parallel imports is primarily for the wholesaler rather than the national health system of the importing country. Moreover, it certainly does not benefit the individual consumers in those countries.

“In many ways, re-importation as a cure is typical of the American approach to health care issues – a quick fix that engenders a range of collateral problems, each of which is also thought to be amenable to a quick fix,” writes Ferguson.

The sponsors of the various US bills seem to believe that they will be able to legislate away all of the obstacles to accessing as many drugs via Canada as the American market might demand. However, this ignores the root causes of their pricing problems. This also runs the risk of any attempt by Canada to block re-exports as being seen as unfriendly.

As Ferguson explains, “Canadians, therefore, not only have to convince Americans that their proposals would be harmful to us; we also have to explain to them the source of their price problem.”

Ferguson recommends the Canadian government to revive a proposal made by former federal minister of health Ujjal Dosanjh that would give the minister of health the authority to block the large-scale export of drugs from Canada.

This would not stop individual Americans from buying their drugs in Canada nor would it present an obstacle to Canadian generic manufacturers exporting into the US market.

Ferguson urges that Ottawa must not be complacent on this issue as this could seriously disrupt the Canadian market. Ottawa should instead make our own supply chain more robust, specifically by ending our reliance on just one or two countries for supply, not only for drugs, but for a range of essential commodities.

More importantly, the Canadian government needs to make it plain that re-importation is not a cure for the drug price problems facing our Southern friends.

As Ferguson concludes, “we have to make it plain to the US that the proposed re-importation policy will not work – for either country.”

Read the full paper here.

***
Brian Ferguson is Professor of Economics at the Department of Economics and Finance at the University of Guelph. He is a Faculty Associate of the Canadian Centre for Health Economics.

For more information, media are invited to contact:

Brett Byers
Communications and Digital Media Manager
613-482-8327 x105
brett.byers@macdonaldlaurier.ca

Tags: Brian FergusonCanada-US relationsDrugsHealth PolicyhealthcarePress Release
Previous Post

Addressing the crisis of distrust in police: Jamil Jivani in the National Post

Next Post

‘ASEAN centrality’ and the emerging great power competition: K. Yhome for the Observer Research Foundation

Related Posts

Prioritizing gender identity over sex in prisons endangers female prisoners
Releases

Prioritizing gender identity over sex in prisons endangers female prisoners

February 6, 2023
Greedflation? It’s a government thing: Philip Cross in the Financial Post
Columns

Jagmeet Singh uses confusion about private care to support the status quo: Shawn Whatley in the National Post

February 6, 2023
Prioritizing gender identity over sex in prisons endangers female prisoners
Papers

Rights and wrongs: How gender self-identification policy places women at risk in prison

February 6, 2023
Next Post
‘ASEAN centrality’ and the emerging great power competition: K. Yhome for the Observer Research Foundation

‘ASEAN centrality’ and the emerging great power competition: K. Yhome for the Observer Research Foundation

Macdonald-Laurier Institute

323 Chapel Street, Suite #300
Ottawa, Ontario
K1N 7Z2 Canada

613.482.8327

info@macdonaldlaurier.ca
MLI directory

Follow us on

Newsletter Signup

First Name
Last Name
Email Address

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

Inside Policy Magazine

  • Current Issue
  • Back Issues
  • Advertising
  • Inside Policy Blog
  • Privacy Policy

© 2021 Macdonald-Laurier Institute. All Rights reserved.

No Result
View All Result
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Energy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media

© 2021 Macdonald-Laurier Institute. All Rights reserved.

IDEAS CHANGE THE WORLD!Have the latest Canadian thought leadership delivered straight to your inbox.
First Name
Last Name
Email address

No thanks, I’m not interested.